MedTrace Logo

3Mixtatin and MTA Vital Pulpotomy in Primary Molars

NCT06478940 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-06-27

No results posted yet for this study

Summary

The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.

Conditions

  • Pulp Disease, Dental
  • Deciduous Teeth

Interventions

DRUG

3 mixtatin pulpotomy

pulp treatment with applying 3mixture of antibiotic (Metronidazole, cefixime, and Ciprofloxacin) along with simvastatin

DRUG

MTA pulpotomy

pulp treatment with applying MTA

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Randa y Abd Al Gawad, professor · Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

  • Yasmin M Yousry, Associate professor · Assistant Professor of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-08-01
Completion
2025-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06478940 on ClinicalTrials.gov